Harmony Biosciences
HRMY
HRMY
267 hedge funds and large institutions have $1.66B invested in Harmony Biosciences in 2025 Q1 according to their latest regulatory filings, with 41 funds opening new positions, 99 increasing their positions, 85 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
267
Holders Change
+22
Holders Change %
+8.98%
% of All Funds
3.63%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.04%
New
41
Increased
99
Reduced
85
Closed
18
Calls
$4.95M
Puts
$1.57M
Net Calls
+$3.38M
Net Calls Change
+$889K
Top Buyers
| 1 |
NVCHI
New Vernon Capital Holdings II
Morristown,
New Jersey
|
+$14.3M |
| 2 |
Renaissance Technologies
New York
|
+$9.02M |
| 3 |
JPMorgan Chase & Co
New York
|
+$8.26M |
| 4 |
LSV Asset Management
Chicago,
Illinois
|
+$7.92M |
| 5 |
Allianz Asset Management
Munich,
Germany
|
+$6.92M |
Top Sellers
| 1 |
Pacer Advisors
Malvern,
Pennsylvania
|
-$59.2M |
| 2 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
-$49.9M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$16.8M |
| 4 |
BlackRock
New York
|
-$15.1M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
-$11M |
